Capital Management Associates NY reduced its stake in Safeguard Scientifics, Inc (NYSE:SFE) by 39.8% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 30,700 shares of the asset manager’s stock after selling 20,300 shares during the quarter. Capital Management Associates NY’s holdings in Safeguard Scientifics were worth $344,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Granahan Investment Management Inc. MA lifted its holdings in Safeguard Scientifics by 20.8% in the 3rd quarter. Granahan Investment Management Inc. MA now owns 646,492 shares of the asset manager’s stock worth $8,631,000 after purchasing an additional 111,370 shares during the last quarter. Pinebridge Investments L.P. lifted its holdings in Safeguard Scientifics by 147.5% in the 3rd quarter. Pinebridge Investments L.P. now owns 24,984 shares of the asset manager’s stock worth $333,000 after purchasing an additional 14,890 shares during the last quarter. State Street Corp lifted its holdings in shares of Safeguard Scientifics by 7.9% during the second quarter. State Street Corp now owns 383,000 shares of the asset manager’s stock worth $4,558,000 after buying an additional 28,161 shares during the last quarter. Legal & General Group Plc lifted its holdings in shares of Safeguard Scientifics by 16.9% during the third quarter. Legal & General Group Plc now owns 63,234 shares of the asset manager’s stock worth $844,000 after buying an additional 9,157 shares during the last quarter. Finally, Prudential Financial Inc. lifted its holdings in shares of Safeguard Scientifics by 60.7% during the second quarter. Prudential Financial Inc. now owns 27,281 shares of the asset manager’s stock worth $325,000 after buying an additional 10,300 shares during the last quarter. Hedge funds and other institutional investors own 76.46% of the company’s stock.

A number of research analysts have recently commented on SFE shares. Keefe, Bruyette & Woods reiterated a “mkt perform” rating and set a $13.25 price target on shares of Safeguard Scientifics in a report on Wednesday, December 6th. Zacks Investment Research lowered Safeguard Scientifics from a “buy” rating to a “hold” rating in a report on Tuesday, January 2nd. Finally, ValuEngine lowered Safeguard Scientifics from a “hold” rating to a “sell” rating in a report on Tuesday, November 14th.

Safeguard Scientifics, Inc (SFE) opened at $12.60 on Thursday. Safeguard Scientifics, Inc has a 1-year low of $10.65 and a 1-year high of $14.40. The company has a market capitalization of $257.20, a P/E ratio of -2.80 and a beta of 1.36. The company has a current ratio of 1.03, a quick ratio of 1.03 and a debt-to-equity ratio of 0.45.

ILLEGAL ACTIVITY WARNING: “Capital Management Associates NY Has $344,000 Position in Safeguard Scientifics, Inc (SFE)” was originally reported by Daily Political and is the sole property of of Daily Political. If you are accessing this piece of content on another website, it was illegally copied and republished in violation of United States & international copyright and trademark legislation. The original version of this piece of content can be read at https://www.dailypolitical.com/2018/02/08/capital-management-associates-ny-has-344000-position-in-safeguard-scientifics-inc-sfe.html.

Safeguard Scientifics Profile

Safeguard Scientifics, Inc is engaged in providing capital to technology companies within the fields of healthcare, financial services and digital media. The Company holds interest in companies, which it refers to as partner companies. As of December 31, 2016, the Company held interests in 29 non-consolidated partner companies.

Want to see what other hedge funds are holding SFE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Safeguard Scientifics, Inc (NYSE:SFE).

Institutional Ownership by Quarter for Safeguard Scientifics (NYSE:SFE)

Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.